AU2023395547A1 - 2-azabicyclo[3.1.1]heptane compound - Google Patents
2-azabicyclo[3.1.1]heptane compoundInfo
- Publication number
- AU2023395547A1 AU2023395547A1 AU2023395547A AU2023395547A AU2023395547A1 AU 2023395547 A1 AU2023395547 A1 AU 2023395547A1 AU 2023395547 A AU2023395547 A AU 2023395547A AU 2023395547 A AU2023395547 A AU 2023395547A AU 2023395547 A1 AU2023395547 A1 AU 2023395547A1
- Authority
- AU
- Australia
- Prior art keywords
- group
- atom
- methyl
- compound
- azabicyclo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022-201488 | 2022-12-16 | ||
| JP2022201488 | 2022-12-16 | ||
| PCT/JP2023/044987 WO2024128305A1 (ja) | 2022-12-16 | 2023-12-15 | 2-アザビシクロ[3.1.1]ヘプタン化合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2023395547A1 true AU2023395547A1 (en) | 2025-06-26 |
Family
ID=91485946
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2023395547A Pending AU2023395547A1 (en) | 2022-12-16 | 2023-12-15 | 2-azabicyclo[3.1.1]heptane compound |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP4635944A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JPWO2024128305A1 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20250112793A (cg-RX-API-DMAC7.html) |
| CN (1) | CN120603816A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023395547A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2025006722A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202430169A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2024128305A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20260012686A (ko) * | 2024-07-18 | 2026-01-27 | (주)셀트리온 | 신규한 오렉신 2 수용체 작용제 및 이의 용도 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015056100A2 (en) | 2013-10-14 | 2015-04-23 | Marvell World Trade Ltd. | Systems and methods for graphics process units power management |
| SG11201604639YA (en) | 2013-12-12 | 2016-07-28 | Univ Tsukuba | Sulfonamide derivative or pharmaceutically acceptable acid addition salt thereof |
| JP6359924B2 (ja) | 2014-09-17 | 2018-07-18 | トヨタ自動車株式会社 | 非接触送受電システム |
| SG11201806429PA (en) | 2016-02-04 | 2018-08-30 | Takeda Pharmaceuticals Co | Substituted piperidine compound and use thereof |
| US10428023B2 (en) * | 2017-08-03 | 2019-10-01 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and use thereof |
| CA3074059A1 (en) * | 2017-09-01 | 2019-03-07 | Chronos Therapeutics Limited | Substituted 2-azabicyclo[3.1.1]heptane and 2-azabicyclo[3.2.1]octane derivatives as orexin receptor antagonists |
| WO2019081939A1 (en) * | 2017-10-25 | 2019-05-02 | Chronos Therapeutics Limited | 2-AZABICYCLO [3.1.1] DERIVATIVES AS ANTAGONISTS OF OREXIN-1 AND OREXIN-2 RECEPTORS |
| PE20211700A1 (es) * | 2019-01-31 | 2021-09-01 | Takeda Pharmaceuticals Co | Compuesto heterociclico y su uso |
| WO2020167701A1 (en) | 2019-02-13 | 2020-08-20 | Merck Sharp & Dohme Corp. | Pyrrolidine orexin receptor agonists |
| KR20260083444A (ko) | 2019-11-25 | 2026-06-05 | 알케르메스,인코포레이티드 | 치환된 마크로사이클릭 화합물 및 관련 치료 방법 |
| PE20221730A1 (es) | 2019-11-27 | 2022-11-07 | Sumitomo Pharma Co Ltd | Derivado de cicloalquilurea |
| CN119235864A (zh) | 2020-07-17 | 2025-01-03 | 卫材R&D管理有限公司 | 取代的哌啶化合物及其用途 |
| US12503475B2 (en) | 2020-09-03 | 2025-12-23 | Centessa Pharmaceuticals (Uk) Limited | Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists |
| CN116969888A (zh) * | 2022-04-24 | 2023-10-31 | 优领医药科技(上海)有限公司 | 含环丙基并环类衍生物、其药学上可接受的盐及其制备方法和应用 |
-
2023
- 2023-12-15 JP JP2024564440A patent/JPWO2024128305A1/ja active Pending
- 2023-12-15 KR KR1020257019334A patent/KR20250112793A/ko active Pending
- 2023-12-15 AU AU2023395547A patent/AU2023395547A1/en active Pending
- 2023-12-15 CN CN202380092851.0A patent/CN120603816A/zh active Pending
- 2023-12-15 TW TW112149084A patent/TW202430169A/zh unknown
- 2023-12-15 EP EP23903586.8A patent/EP4635944A1/en active Pending
- 2023-12-15 WO PCT/JP2023/044987 patent/WO2024128305A1/ja not_active Ceased
-
2025
- 2025-06-09 MX MX2025006722A patent/MX2025006722A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN120603816A (zh) | 2025-09-05 |
| JPWO2024128305A1 (cg-RX-API-DMAC7.html) | 2024-06-20 |
| EP4635944A1 (en) | 2025-10-22 |
| WO2024128305A1 (ja) | 2024-06-20 |
| KR20250112793A (ko) | 2025-07-24 |
| TW202430169A (zh) | 2024-08-01 |
| MX2025006722A (es) | 2025-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2018243463C1 (en) | 11,13-modified saxitoxins for the treatment of pain | |
| EP3601290B1 (en) | 11,13-modified saxitoxins for the treatment of pain | |
| TW202311260A (zh) | 含有亞磺醯亞胺基的atr抑制劑化合物 | |
| US20220009938A1 (en) | 11,13-modified saxitoxins for the treatment of pain | |
| JP5860199B2 (ja) | Nk1アンタゴニストとしてのピロリジンおよびピペリジンの誘導体 | |
| TW201204346A (en) | Novel hydroxamic acid derivative | |
| CN105829286A (zh) | 作为lta4h抑制剂的杂芳基丁酸衍生物 | |
| UA123071C2 (uk) | ІНГІБІТОРИ ДОФАМІН-<font face="Symbol">b</font>-ГІДРОКСИЛАЗИ | |
| WO2023059792A1 (en) | Coronavirus non-structural protein 3 degrading compounds | |
| CA3234990A1 (en) | Rxfp1 agonists | |
| Žukauskaitė et al. | Synthesis of new functionalized aziridine-2-and azetidine-3-carboxylic acid derivatives of potential interest for biological and foldameric applications | |
| WO2025160286A1 (en) | 2-aryl cycloalkyl and heterocycloalkyl inhibitors of nav1.8 for the treatment of pain | |
| TW202304864A (zh) | 1,3-取代的環丁基衍生物及其用途 | |
| TWI501953B (zh) | 環己烷衍生物化合物 | |
| TW202430169A (zh) | 2-氮雜雙環[3.1.1]庚烷化合物 | |
| WO2023107487A1 (en) | Lonp1 inhibitor compounds, uses and methods | |
| CA3180417A1 (en) | Synthesis of (2s,5r)-5-(2-chlorophenyl)-1-(2'-methoxy-[1,1'-biphenyl]-4-carbonyl)pyrrolidine-2-carboxylic acid | |
| EP4685151A1 (en) | Proteasome inhibitor | |
| TW201625588A (zh) | 環狀胺衍生物 | |
| HK40120402A (en) | Dihydrooxadiazinone compound and pharmaceutical use thereof | |
| RU2778455C2 (ru) | 11,13-модифицированные сакситоксины для лечения боли | |
| EP4541791A1 (en) | Dihydrooxadiazinone compound and pharmaceutical use thereof | |
| EP4709486A1 (en) | Heteroaryl compounds as ligand directed degraders of irak4 | |
| TWI670262B (zh) | 新穎雜芳基丁酸衍生物 | |
| CA3253076A1 (en) | COMPOUNDS AND PROCESSES FOR DEGRADING CASEIN KINASE 1 ALPHA |